Multifocal Stevens-Johnson syndrome after concurrent phenytoin and cranial and thoracic radiation treatment, a case report

Radiation Oncology

Volumn 5, Issue 1, 2010, Pages

  Kandil, Abdullah O ^a   Dvorak, Tomas ^b   Mignano, John ^b   Wu, Julian K ^b   Zhu, Jay Jiguang ^b  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b TUFTS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; DEXAMETHASONE; ETIRACETAM; FENTANYL; FLUCONAZOLE; HYDROMORPHONE; PHENOBARBITAL; PHENYTOIN; ANTICONVULSIVE AGENT;

ADULT; ARTICLE; BACK; BONE METASTASIS; BRAIN METASTASIS; CASE REPORT; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG EFFICACY; ERYTHEMA MULTIFORME; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MALE; MOUTH; PAIN; PROSTATE CANCER; RADIOTHERAPY; RASH; SCALP; SEIZURE; SKULL; STEVENS JOHNSON SYNDROME; THORAX; BRAIN TUMOR; METASTASIS; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; PATHOLOGY; PROSTATE TUMOR; SKULL IRRADIATION; THORAX TUMOR; TREATMENT OUTCOME;

ANTICONVULSANTS; BRAIN NEOPLASMS; COMBINED MODALITY THERAPY; CRANIAL IRRADIATION; HUMANS; MALE; MIDDLE AGED; PHENYTOIN; PROSTATIC NEOPLASMS; STEVENS-JOHNSON SYNDROME; THORACIC NEOPLASMS; TREATMENT OUTCOME;

EID: 77953005478     PISSN: None     EISSN: 1748717X     Source Type: Journal    
DOI: 10.1186/1748-717X-5-49     Document Type: Article

References (21)

1. Hartsell WF, Santosh Y. Palliation of Bone Metastases,. Principles and Practice of Radiation Oncology 2008, 1992-1996. Philadelphia: Lippincott, Williams & Wilkins, Halperin EC, Perez CA, Brady LW, 5.
2. Browne TR. Pharmacokinetics of antiepileptic drugs. Neurology 1998, 51(5 Suppl 4):S2-7.
3. Roujeau JC, Kelly JP, Naldi L, Rzany B, Stern RS, Anderson T, Auquier A, Bastuji-Garin S, Correia O, Locati F, Mockenhaupt M, Paoletti C, Shapiro S, Shear N, Schopf E, Kaufman D. Medication use and the risk of Stevens-Johnson syndrome or toxic epidermal necrolysis. N Engl J Med 1995, 333:1600-1607. 10.1056/NEJM199512143332404, 7477195.
4. Fine JD. Management of acquired bullous skin diseases. N Engl J Med 1995, 333:1475-1484. 10.1056/NEJM199511303332207, 7477149.
5. Garcia-Doval I, LeCleach L, Bocquet H, Otero XL, Roujeau JC. Toxic epidermal necrolysis and Stevens-Johnson syndrome: does early withdrawal of causative drugs decrease the risk of death?. Arch Dermatol 2000, 136:323-327. 10.1001/archderm.136.3.323, 10724193.
6. Phoon WH, Chan MO, Rajan VS, Tan KJ, Thirumoorthy T, Goh CL. Stevens-Johnson syndrome associated with occupational exposure to trichloroethylene. Contact Dermatitis 1984, 10:270-276. 10.1111/j.1600-0536.1984.tb00145.x, 6734188.
7. Mockenhaupt M, Messenheimer J, Tennis P, Schlingmann J. Risk of Stevens-Johnson syndrome and toxic epidermal necrolysis in new users of antiepileptics. Neurology 2005, 64:1134-1138.
8. Arif H, Buchsbaum R, Weintraub D, Koyfman S, Salas-Humara C, Bazil CW, Resor SR, Hirsch LJ. Comparison and predictors of rash associated with 15 antiepileptic drugs. Neurology 2007, 68:1701-1709. 10.1212/01.wnl.0000261917.83337.db, 17502552.
9. Man CB, Kwan P, Baum L, Yu E, Lau KM, Cheng AS, Ng MH. Association between HLA-B*1502 allele and antiepileptic drug-induced cutaneous reactions in Han Chinese. Epilepsia 2007, 48:1015-1018. 10.1111/j.1528-1167.2007.01022.x, 17509004.
10. Duncan KO, Tigelaar RE, Bolognia JL. Stevens-Johnson syndrome limited to multiple sites of radiation therapy in a patient receiving phenobarbital. J Am Acad Dermatol 1999, 40:493-496. 10.1016/S0190-9622(99)70508-6, 10071329.
11. Ahmed I, Reichenberg J, Lucas A, Shehan JM. Erythema multiforme associated with phenytoin and cranial radiation therapy: a report of three patients and review of the literature. Int J Dermatol 2004, 43:67-73. 10.1111/j.1365-4632.2004.01934.x, 14693027.
12. Cockey GH, Amann ST, Reents SB, Lynch JW. Stevens-Johnson syndrome resulting from whole-brain radiation and phenytoin. Am J Clin Oncol 1996, 19:32-34. 10.1097/00000421-199602000-00007, 8554032.
13. Aydin F, Cokluk C, Senturk N, Aydin K, Canturk MT, Turanli AY. Stevens-Johnson syndrome in two patients treated with cranial irradiation and phenytoin. European Academy of Dermatology and Venereology 2006, 20:588-590.
14. Micali G, Linthicum K, Han N, West DP. Increased risk of erythema multiforme major with combination anticonvulsant and radiation therapies. Pharmacotherapy 1999, 19:223-227. 10.1592/phco.19.3.223.30917, 10030773.
15. Barbosa LA, Teixeira CR. Erythema multiforme associated with prophylactic use of phenytoin during cranial radiation therapy. American Journal of Health-System Pharmacy 2008, 65:1048-1050. 10.2146/ajhp060580, 18499877.
16. Gonzalez-Sicilia L, Cano A, Serrano M, Hernandez J. Stevens-Johnson syndrome associated with gabapentin. American Journal of Medicine 1998, 105:455.
17. Lim DA, Tarapore P, Chang E, Burt M, Chakalian L, Barbaro N, Chang S, Lamborn KR, McDermott MW. Safety and feasibility of switching from phenytoin to levetiracetam monotherapy for glioma-related seizure control following craniotomy: a randomized phase II pilot study. J. Neuro-Onco 2009, 93:349-354.
18. French JA, Kanner AM, Bautista J, Abou-Khalil B, Browne T, Harden CL, Theodore WH, Bazil C, Stern J, Schachter SC, Bergen D, Hirtz D, Montouris GD, Nespeca M, Gidal B, Marks WJ, Turk WR, Fischer JH, Bourgeois B, Wilner A, Faught RE, Sachdeo RC, Beydoun A, Glauser TA. Efficacy and tolerability of the new antiepileptic drugs I: Treatment of new onset epilepsy: Report of the Therapeutics and Technology Assessment Subcommittee and Quality Standards Subcommittee of the American Academy of Neurology and the American Epilepsy Society. Neurology 2004, 62:1252-1260.
19. French JA, Kanner AM, Bautista J, Abou-Khalil B, Browne T, Harden CL, Theodore WH, Bazil C, Stern J, Schachter SC, Bergen D, Hirtz D, Montouris GD, Nespeca M, Gidal B, Marks WJ, Turk WR, Fischer JH, Bourgeois B, Wilner A, Faught RE, Sachdeo RC, Beydoun A, Glauser TA. Efficacy and tolerability of the new antiepileptic drugs II: treatment of refractory epilepsy: report of the Therapeutics and Technology Assessment Subcommittee and Quality Standards Subcommittee of the American Academy of Neurology and the American Epilepsy Society. Neurology 2004, 62:1261-1273.
20. Berkovic SF, Knowlton RC, Leroy RF, Schiemann J, Falter U, . On behalf of the Levetiracetam N01057 Study Group Placebo-controlled study of levetiracetam in idiopathic generalized epilepsy. Neurology 2007, 69:1751-1760. 10.1212/01.wnl.0000268699.34614.d3, 17625106, On behalf of the Levetiracetam N01057 Study Group.
21. Jones KE, Puccio AM, Harshman KJ, Falcione B, Benedict N, Jankowitz BT, Stippler M, Fischer M, Sauber-Schatz EK, Fabio A, Darby JM, Okonkwo DO. Levetiracetam versus phenytoin for seizure prophylaxis in severe traumatic brain injury. Neurosurgical Focus 2008, 25:E3. 10.3171/FOC.2008.25.10.E3, 18828701.